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Abstract
Temporal lobe epilepsy (TLE) is a neurological condition associated with neuron loss, axon sprouting, and hippocampal
sclerosis, which results in modified synaptic circuitry. Cannabinoids appear to be anti-convulsive in patients and animal
models of TLE, but the mechanisms of this effect are not known. A pilocarpine-induced status epilepticus mouse model of
TLE was used to study the effect of cannabinoid agonists on recurrent excitatory circuits of the dentate gyrus using
electrophysiological recordings in hippocampal slices isolated from control mice and mice with TLE. Cannabinoid agonists
WIN 55,212-2, anandamide (AEA), or 2-arachydonoylglycerol (2-AG) reduced the frequency of spontaneous and
tetrodotoxin-resistant excitatory postsynaptic currents (EPSCs) in mice with TLE, but not in controls. WIN 55,212-2 also
reduced the frequency of EPSCs evoked by glutamate-photolysis activation of other granule cells in epileptic mice.
Secondary population discharges evoked after antidromic electrical stimulation of mossy fibers in the hilus were also
attenuated by cannabinoid agonists. Agonist effects were blocked by the cannabinoid type 1 receptor (CB1R) antagonist
AM251. No change in glutamate release was observed in slices from mice that did not undergo status epilepticus. Western
blot analysis suggested an up-regulation of CB1R in the dentate gyrus of animals with TLE. These findings indicate that
activation of CB1R present on nerve terminals can suppress recurrent excitation in the dentate gyrus of mice with TLE. This
suggests a mechanism for the anti-convulsive role of cannabinoids aimed at modulating receptors on synaptic terminals
expressed de novo after epileptogenesis.
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Introduction
Development of temporal lobe epilepsy (TLE) is often associated
with gliosis, neuron loss, axon sprouting, and synaptic reorgani-
zation in temporal lobe brain structures. These changes occur
variably in concert with the development of spontaneous recurrent
seizures in humans and in animal models of inducible TLE. In
particular, mossy fiber sprouting in the dentate gyrus is a widely
studied correlate of adult TLE development [1,2,3,4,5,6,7]. A
dominant hypothesis regarding the outcome of this structural
metamorphosis is that newly sprouted mossy fibers form recurrent
synaptic connections with other granule cells, thus accounting for
increased excitability of the dentate gyrus under experimental
conditions [8,9,10,11,12,13]. The dentate gyrus is particularly
amenable to study in TLE models because of the well-defined
nature of the anatomical and functional changes, but synaptic
reorganization and recurrent excitation likely also occur in other
regions [7,14,15,16,17]. The well-described changes in the dentate
gyrus may serve as a model for altered synaptic activity in other
affected brain areas.
Cannabinoids have been implicated for the treatment of several
neurological disorders associated with neural excitability changes
[18,19,20,21]. However, using cannabinoids to treat epilepsy has
been controversial [22]. In the brain, cannabinoids act mainly at
G protein-coupled, cannabinoid type 1 receptors (CB1R) [23].
The usual cellular location for the CB1R in the hippocampus and
other brain regions is synaptic terminals of GABAergic interneu-
rons and select glutamatergic principal cells [24,25,26,27,28].
Typically, binding CB1R diminishes synaptic inhibition or
excitation by suppressing GABA or glutamate release, respectively.
The presence of CB1R on glutamatergic terminals might thus
contribute to anti-epileptic activity of cannabinoids by reducing
glutamate release, whereas receptors located on GABA terminals
might exacerbate seizures by limiting GABA release. Regional
CB1R expression changes have been detected in tissue from
human patients and animal TLE models [29,30]. Systemic
cannabinoid treatment suppresses seizures and increases seizure
threshold in epileptic rats [31], whereas CB1R antagonists cause
seizure-like activity in hippocampal culture models of acquired
epilepsy [32] and treatment with CB1R antagonists may
exacerbate seizures in patients with TLE [33]. Cannabinoid-
mediated responses that are consistent with their putative anti-
convulsive actions have not been adequately investigated, and
cellular effects on synaptically-reorganized tissue from epileptic
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animals are unknown. We therefore tested the hypothesis
that glutamate release is suppressed by CB1R activation in
the reorganized dentate gyrus granule cell layer of animals with
TLE.
Methods
Ethics Statement
All procedures were carried out in accordance with NIH
Guidelines and were approved by the Tulane University and
University of Kentucky Animal Care and Use Committees.
Animals and Pilocarpine-injection
Adult male CD1 mice weighing 25–30g were housed individ-
ually on a 12-hour day/night cycle. Food and water were available
ad libitum. The animals were housed at least 7 days prior to
treatment. Mice were administered an intraperitoneal (i.p.)
injection of methylscopolamine (1 mg/kg) in sterile saline vehicle
(0.9% NaCl; 0.1 ml total volume) 15–30 min prior to injection of
pilocarpine to reduce the peripheral cholinergic effects of the
pilocarpine. Experimental animals were then injected i.p. with a
single dose of pilocarpine (280–290 mg/kg) as described previously
[7]. Control mice were age-matched with treated mice and were
administered a comparable volume of vehicle or were not injected
after the initial methylscopolamine treatment.
Seizure behavior was observed for at least 2 hours starting
immediately after the pilocarpine injection. The category and the
number of generalized convulsive seizures in each K hour period
were tallied. A modified version of the seizure scale described by
Racine [34] was used to identify seizure severity. Special attention
was given to convulsive seizures (i.e., categories 3 to 5) as they were
correlated previously with the eventual development of spontane-
ous seizures and mossy fiber sprouting [7,8]. Convulsive seizures
most often included unilateral limb myoclonus, loss of postural
control and repetitive jumping. Seizures were typically of 30–90s
duration and were separated by periods of relative inactivity of
variable duration. The periods between convulsive seizures were
marked by continuous low-level seizure-like activity (i.e., categories
1-2) that typically included continuous head bobbing, chewing,
stiff tail, and intermittent wet dog shakes. A mouse that
experienced a minimum of 3 generalized convulsive seizure events
within 2 hours following pilocarpine injection was considered to
have undergone status epilepticus (SE). In addition to standard
rodent chow and water, mice were supplied with water-moistened
chow and a 5% sucrose solution in water in a petri dish inside the
cage for at least 4 days after SE induction to help replenish fluids.
Mice were housed individually for 4–10 weeks after pilocarpine-
induced SE prior to electrophysiological analysis. Seizure activity
was assessed by passive observation for 4–6 hr/wk beginning 3
weeks after SE. Once spontaneous seizures were detected, animals
that survived SE became candidates for in vitro experiments. In
the event no seizures were observed, animals were used at 10
weeks post-treatment.
Slice preparation and electrophysiological recording
Mice were anesthetized by halothane inhalation and then
decapitated. The brains were rapidly removed and immersed in
oxygenated (95% O2/5% CO2) ice-cold (0–4uC) artificial
cerebrospinal fluid (ACSF) containing (in mM): 124 NaCl, 3
KCl, 26 NaHCO3, 11 glucose, 2 CaCl2, and 1.3 MgCl2,
pH = 7.3–7.4, with an osmolality of 290–305 mOsm/kg. Brains
were then blocked and glued to a sectioning stage and transverse
slices (300 mm) of the hippocampal formation (i.e., approximately
horizontally through the ventral 2/3 of the hippocampal
formation) were cut in cold oxygenated ACSF using a vibrating
microtome (Vibratome Series 1000; Technical Products Intl, St
Louis, MO, USA). The hippocampus was then separated from the
surrounding tissue, being sure to completely remove the entorhinal
cortex. Slices were then transferred to a storage chamber, where
they were immersed in warm (32–35uC) and oxygenated ACSF.
Extracellular field potential recordings: Field-potential record-
ings were obtained from granule cells in the dentate gyrus using a
glass micropipette containing 1M NaCl placed near the apex of
the granule cell layer. Voltage signals were recorded using an
Axopatch 1D amplifier (Axon Instruments; Union City, CA), low-
pass filtered at 2–5 kHz, digitized at 88 kHz (Neurocorder, Cygnus
Technology, Delaware Water Gap, PA), stored on videotape, and
acquired to a PC-style computer using a Digidata 1320A and
pClamp programs (Clampex 8; Axon Instruments, Union City,
CA, USA).
Whole-cell patch-clamp recordings: After an equilibration
period of 1–2h, granule cells in the dentate gyrus were targeted
for recording under a 406water-immersion objective (NA = 0.8)
with infrared-differential interference contrast (IR-DIC) optics
(Olympus BX-51WI) using a CCD camera. Whole-cell voltage-
clamp recordings from dentate granule cells were made using
patch pipettes with open resistances of 2–5 MV using a
Multiclamp 700A (Molecular Devices, Sunnyvale, CA, USA) or
Axopatch 200B amplifier (Axon Instruments). Signals were low-
pass filtered at 2–5kHz, digitized at 88kHz (Neurocorder, Cygnus
Technology, Delaware Water Gap, PA, USA), and recorded onto
videotape as well as to a PC-style computer (Digidata 1320A or
1440A; Axon Instruments or Molecular Devices). Data were
captured using pCLAMP programs (Axon Instruments or
Molecular Devices) and analyzed using pCLAMP or Mini-analysis
(Synaptosoft, Decatur, GA, USA).
Patch pipettes were pulled from borosilicate glass (Garner Glass
Co., Claremont, CA, USA) and were filled with an intracellular
solution containing (in mM): 130 K+-gluconate, 10 HEPES, 1 NaCl,
1 MgCl2, 1 CaCl2, 3 KOH, 5 EGTA, and 2–4 Mg-ATP. Seal
resistance was typically 1–4 GV and series resistance, measured
from brief voltage steps (10 mV, 5 ms) applied through the recording
pipette was typically ,20 MV, uncompensated. Recordings in
which a .20% change in series resistance was measured during the
recording were excluded from the analysis. Input conductance was
estimated by measuring the current at the end of brief (20–400 ms)
voltage pulses of 5–10 mV. Resting membrane potential (28 mV
correction for liquid junction potential) was determined by
periodically monitoring the voltage at which no current was
measured (i.e. briefly removing voltage-clamp control of the neuron
by switching to I = 0) during the recording.
Electrical stimulation of mossy fibers was made using a
concentric bipolar platinum-iridium electrode (125 mm diameter;
FHC, Inc. Bowdoinham, ME) placed in the hilus. Stimulation
intensity was initially adjusted to the minimum intensity required
to evoke a single antidromic population spike, which was
considered to be the threshold stimulation intensity (T). Stimula-
tion-response characteristics were obtained for each slice using
increasing multiples of T. At least 5 stimuli at 20–120s intervals
were made at each multiple of T.
Chemical activation of intact granule cell circuits was done by
photolytic ‘‘uncaging’’ of glutamate in the dentate gyrus (i.e.,
glutamate photoactivation), similar to previous descriptions
[8,12,35]. L-glutamatic acid, c-(-carboxy-2-nitrobenzyl) ester,
trifluoroacetic acid salt (i.e., CNB-caged glutamate, 250 mM;
Invitrogen, Carlsbad, CA, USA), which does not bind glutamate
receptors, was added to re-circulating ACSF and was ‘‘uncaged’’
using brief exposure to UV light. Epifluorescence illumination
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through a UV filter (excitation, 360–70 nm; emission long pass,
420 nm; dichroic, 400 nm; Chroma Technology, Rockingham,
VT) was used to direct UV light into the slice through the 40x
objective used to obtain the recording, which was moved
progressively further away from the recorded cell until a
photolysis-mediated increase in synaptic events was found in the
absence of a direct inward glutamate-mediated current. Exposure
time (10 ms) was electronically controlled using a Uniblitz shutter
(Vincent Associates, Rochester, NY) and apertures along the light
path confined the diameter of effective uncaging to approximately
50 mm. Opening the shutter with no UV filter or with other filters
in place (e.g., FITC) did not result in uncaging. Glutamate was
uncaged in at least five points along the length of the granule cell
layer, including the apex and the tips of the supra- and
infrapyramidal blades, as well as in the hilus and proximal CA3
pyramidal regions.
Drug application
Population and whole cell recordings were usually done in the
absence of Mg2+ in the ACSF in order to remove the Mg2+-
dependent blockade of the NMDA receptors and expose circuit
excitability [8,15]. Added to the ACSF for specific experiments
were the GABAA receptor antagonist, bicuculline methiodide
(30 mM; Sigma), tetrodotoxin (TTX; 1–2 mM; Sigma or Alomone
labs, Jerusalem, Israel), the glutamate AMPA/kainate receptor
antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX; 10 mM;
Sigma), and the NMDA receptor antagonist DL-5-aminopho-
sphonovaleric acid (AP-5; 50 mM; Sigma). The synthetic canna-
binoid agonist (R)-(+)-[2,3-Dihydro-5-methyl-3[(4-morpholinyl)-
methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)metha-
none (WIN55,212-2; 1–10 mM; Sigma), the endogenous cannab-
inoid ligands, arachidonoylethanolamide (anandamide, AEA; 1–
10 mM; Tocris) and 2-arachidonylglycerol (2-AG; 1-10 mM; Tocris),
and the CB1R antagonist/inverse agonist, N-(Piperidin-1-yl)-5-(4-
iodophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carbox-
amide (AM-251; 10 mM; Tocris) were used to activate and block
CB1R-mediated responses, respectively. In general, antagonists and
toxins were added continuously for at least 20 min prior to response
measurements; agonists were bath applied for 5–10 min.
Tissue staining
At the end of the experiment, slices were placed in 0.37%
sodium sulfide solution in 0.1M NaHPO4 buffer for 25 minutes
and then fixed overnight in 4% paraformaldehyde. The slices were
then rinsed with phosphate buffered saline (PBS; 0.01M) and
placed in 30% sucrose for cryoprotection. After equilibration with
sucrose, 30 mm frozen sections were made using a cryostat,
mounted on charged slides (Superfrost Plus; Fisher Scientific), and
air-dried overnight. Timm’s and Nissl staining was performed to
reveal mossy fiber and cellular distribution patterns using the
protocols used previously [7]. Timm-stained sections were assessed
semi-quantitatively using the rating scale of Tauck and Nadler [4],
where a score of zero indicated little or no Timm staining in the
granule cell layer; 1 indicated mild, patchy staining in the granule
cell layer; 2 indicated moderate continuous staining through the
granule cell layer with discontinuous, punctate staining in the
inner molecular layer; and 3 indicated a continuous band of
intense staining in the inner molecular layer. Mossy fiber sprouting
scores are reported as the average of assessments from five to eight
sections per animal.
Western Blot detection and quantification
Transverse sections of the hippocampus (400 mM thickness)
were made from control and pilocarpine-treated mice that
survived status epilepticus using a vibratome, and the dentate
gyrus was micro-dissected to include the molecular layer. The
samples were homogenized at 4uC in lysis buffer (0.5M HEPES,
3M NaCl, 1M MgCl2, 0.5M EDTA, 0.1M DTT, 10% SDS, 10%
deoxycholate and 0.3% Triton X-100) and centrifuged at 13000
rpm at 4uC for 10 minutes. The supernatant was collected leaving
the pellet behind. Proteins were quantified using Bradford protein
assay. Each lane was loaded with 15 mg of protein in 10%
Tris?HCl polyacrylamide gels and electrophoresed at 110 V for 60
to 90 min. Proteins were then transferred at 200 mA for 1h to
polyvinylidene difluoride membranes for Western blot analysis.
Membranes were rinsed in PBS and blocked in 1:1 Odyssey
blocking buffer/PBS (Odyssey, Li-COR Biosciences, Lincoln, NE)
for 1h at room temperature. Membranes were then either
incubated 1hr at room temperature or overnight at 4uC, with a
rabbit anti-rat CB1R (1:2500) (Alpha Diagnostic International,
San Antonio, TX) and a rabbit anti-mouse a-actin (1:1000)
primary antiboidies (Sigma, St.Louis, MO) in 1:1 Odyssey
blocking buffer/PBS/0.1% Tween 20. Following four 5-min
washes (PBS + 0.1% Tween 20); membranes were incubated with
fluorescence-conjugated goat anti-rabbit IRDye-680H and goat
anti-rabbit IRDye-800H secondary antibodies (1:5000 Odyssey) in
Odyssey blocking buffer/PBS/0.1% Tween 20 and 0.01% SDS
for 1 hr, followed by four 5-min washes. After a final 10 min PBS
wash, the membranes were dried and blots were scanned by a
densitometer (Odyssey model 9120, Li-COR Biosciences, Lincoln,
NE) to quantify band density. Background density was subtracted
from the CB1R band density and normalized to a-actin, which
was used as the loading control.
Statistical analysis
A value of twice the mean peak-to-peak noise level for a given
recording in control solutions was used as the detection limit for
minimal PSC amplitude (i.e., typically 5–10 pA). For sEPSCs and
mEPSCs, at least 2 min of activity in control and in agonist-
containing ACSF was examined to identify cannabinoid effects on
amplitude and frequency. The effects of drugs on sEPSC and
mEPSC frequencies were analyzed within a recording using the
Kolmogorov-Smirnov (K-S) test. Typically, 100–300 events were
compared for each condition. Pooled results from responding cells
were analyzed using a paired Student’s t-test. For uncaging
experiments, the data collected within a given recording were
analyzed using Kruskal-Wallis test. Western blots were analyzed
using single factor ANOVA. Results are reported as the mean 6
SEM unless indicated otherwise; significance was set at signifi-
cance was set at P,0.01 for the K-S test and P,0.05 for all other
statistical measures.
Results
Histology and synaptic activity in slices from epileptic
mice
As in previous analyses of this model, animals that underwent
SE after pilocarpine injection developed spontaneous seizures, had
mossy fiber sprouting, and showed evidence of recurrent excitatory
circuit formation in the dentate gyrus, whereas animals that did
not undergo SE were normal [7,8]. Similar to those previous
analyses, no major differences in mossy fiber sprouting or synaptic
responsiveness were observed between animals examined at
different times post-treatment within the six seek time-frame for
these studies. Figure 1 illustrates Timm’s staining in an animal that
underwent SE and developed spontaneous seizures compared to a
control animal. Mean Timm scores were 0.7660.19 for 50
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sections from 10 control mice and 2.8760.08 for 45 sections from
9 pilocarpine-treated mice that survived SE.
Extracellular field and whole-cell patch-clamp recordings were
made from 21 untreated animals, 11 pilocarpine-treated animals
that did not undergo SE (injected controls) and 39 pilocarpine-
treated animals that survived SE and experienced at least one
spontaneous seizure. Preliminary tests were done to detect
differences between cells from injected controls and untreated
animals. Since the untreated animals and the injected controls did
not differ behaviorally or physiologically, data from these animals
were combined and considered as control data unless otherwise
noted.
In nominally Mg2+-free ACSF that contained bicuculline
(30 mM), a solution that was meant to expose multisynaptic
glutamatergic connectivity and reduce recurrent GABAergic
inhibition, patch-clamp recordings from granule cells in normal
animals (n = 10) and in injected controls (n = 9) revealed sEPSCs
with an average frequency of 1.4560.17 Hz and 1.2460.15 Hz,
respectively (Fig. 2; P.0.05). In animals that had experienced SE
and developed spontaneous seizures, barrages of sEPSCs were
superimposed on the ongoing sEPSC activity (Fig. 2). The
frequency of sEPSCs in cells from these animals, including those
within the sEPSC barrages, was 3.0360.28 Hz (n = 9), which was
significantly higher than in either of the control groups (P,0.05).
Within a given recording, these values varied little over time, but
variability between cells could be large. Application of glutamate
Figure 1. Timm stain illustrating mossy fiber sprouting into the
dentate gyrus inner molecular layer in pilocarpine-treated
mice. A. Dentate gyrus of a normal mouse. B. Dentate gyrus of a
pilocarpine-treated mouse that survived status epilepticus (SE) showing
mossy fiber sprouting. A1 and B1 are enlarged boxed regions of A and
B. The arrows in B and B1 point to extensive mossy fiber sprouting into
the inner molecular layer of the dentate gyrus. C. Graph showing the
mean Timm score between controls and pilocarpine-treated mice that
survived SE. Asterisk, significant difference between mean scores
(P,0.05).
doi:10.1371/journal.pone.0010683.g001
Figure 2. Increase in synaptic activity in granule cells from pilocarpine-treated mice that survived SE and developed TLE. A. sEPSCs
recorded from granule cell of normal mouse. B. sEPSCs recorded from granule cell of a mouse that was injected with pilocarpine but did not develop
SE. C. sEPSCs and bursting activity recorded from a granule cell of a pilocarpine-treated mouse that developed TLE. D. Trace showing that sEPSCs
were blocked by application of ionotropic glutamate receptor antagonists, CNQX (10 mM) and AP-5 (50 mM). A1 and B1 are expanded boxed regions
of A and B. C1, expansion of the sEPSC showing increased synaptic activity during the burst seen in C. Recordings were made in the absence of
added Mg2+ and the presence of bicuculline (30 mM). E. Bar graph comparing the frequency of sEPSCs among the three groups of animals. Asterisk
indicates significantly higher frequency in cells from mice with TLE (P,0.05).
doi:10.1371/journal.pone.0010683.g002
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antagonists CNQX (10 mM) and AP5 (50 mM) blocked the
sEPSCs and sEPSC barrages (n = 3; Fig 2).
Barrages of sEPSCs were also prevented by addition of TTX
(1–2 mM; Fig. 3), which blocked action potential dependent
synaptic release but did not prevent action potential-independent
miniature EPSCs (mEPSCs), suggesting the barrages were due to
action potentials in afferent neurons. We also determined whether
action potential-independent glutamate release was different
between the two groups. In the presence of TTX, mEPSC
frequency in controls was 1.1460.13 Hz (n = 14) and in
pilocarpine-treated mice was 2.4160.26 Hz (n = 18; P,0.05;
unpaired t-test). These data suggested that granule cells from
pilocarpine-treated mice that survived SE received enhanced
spontaneous glutamatergic synaptic input versus control mice or
mice that did not experience SE after pilocarpine injection.
Activity of local glutamatergic neurons and of additional synaptic
contacts contributed to the enhanced glutamate release.
Effect of CB1R activation on sEPSCs
In Mg2+-free ACSF containing bicuculline, application of AEA
(1–10 mM) to recordings from granule cells in control animals
resulted in no change in amplitude or frequency of sEPSCs
(1.4660.17 Hz control; 1.5560.18 Hz AEA; P.0.05; n = 10). In
granule cells from mice that survived pilocarpine-induced SE,
application of AEA reduced the frequency of sEPSCs from
3.0260.7 Hz in control ACSF to 1.8060.35 Hz in AEA (Fig. 4;
P,0.05; n = 8). In addition, the occurrence of sEPSC bursts was
eliminated by AEA. Application of AEA thus suppressed EPSC
bursting and frequency in these animals. The inhibitory effect of
AEA was prevented by pre-application of the CB1R antagonist
AM-251 (10 mM) (2.6060.52 Hz to 3.0660.67; P.0.05; n = 5;
Fig 4D), indicating the involvement of CB1R in the response. No
significant effect of AM-251 alone on sEPSC frequency was
observed. Application of the synthetic cannabinoid agonist WIN
55,212-2 (1 mM) had similar effects on sEPSC bursts and reduced
the frequency of sEPSCs from 2.7760.67 Hz to 1.7360.43 Hz (5
of 5 cells; P,0.05). Cannabinoid agonists acting at CB1R
suppressed sEPSC bursts in pilocarpine-treated mice that survived
SE, but had no effect on overall excitatory synaptic input in
control mice.
Figure 3. Action potential dependence of epileptiform EPSC
bursts. A. Spontaneous burst activity recorded from a granule cell in a
pilocarpine-treated mouse that survived SE. B. The bursts were
completely blocked by TTX (1 mM), indicating they were action
potential-dependent. Action potential-independent mEPSCs were still
seen in the presence of TTX. A1 and B1 are expanded segments of A
and B respectively. The recordings were made in the absence of Mg2+
and presence of bicuculline (30 mM).
doi:10.1371/journal.pone.0010683.g003
Figure 4. Inhibitory effect of anandamide (AEA) on sEPSCs. A.
Spontaneous bursts of EPSCs observed in a granule cell from a
pilocarpine-treated mouse that survived SE. A1 and A2 are expanded
segments of the events indicated by the arrows. B. AEA (10 mM)
suppressed the epileptiform bursts of activity. B1 and B2 are examples
of individual events from B. C. Bursts were reinstated after 20 minute
wash to normal ACSF. C1 and C2, expanded segments of C. Asterisks
indicate currents preceding the largest amplitude EPSCs in some cases.
The recordings were made in the absence of Mg2+ and the presence of
bicuculline (30 mM). D. Cumulative graph of normalized sEPSC
frequency from control mice and pilocarpine-treated mice that survived
SE and developed TLE before and after application of AEA. Asterisk in D
indicates significant reduction in frequency by AEA (P,0.05). In mice
with TLE, the effect of AEA was prevented by preapplication of the CB1
receptor antagonist AM-251 (10 mM). Number of cells for each
experiment is in parentheses.
doi:10.1371/journal.pone.0010683.g004
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Effect of CB1R activation on mEPSCs
To determine if the effect of CB agonists was due to binding of
receptors on presynaptic terminals, we determined the effect of AEA
on mEPSCs in the presence of TTX. In control animals, AEA did
not change the frequency of mEPSCs (1.3560.25 Hz control vs
1.2560.17 Hz in AEA; n = 5; p.0.05). Application of AEA (10 mM)
in pilocarpine treated mice that survived SE significantly reduced the
frequency of mEPSCs from 2.5360.40 Hz prior to drug application
to 1.8160.22 Hz after drug application (n = 15; P,0.05; Fig. 5).
Within 10 min of application, the frequency of mEPSCs was
decreased by AEA in 8 neurons and unchanged in three cells. In the
remaining four cells, the frequency was transiently increased within
the first 3 min of AEA application. The amplitude of mEPSCs was
not affected by AEA in either group (P.0.05; Fig. 5F).
Since AEA can have effects at non-CB receptors (i.e., TRPV1),
effects of relatively selective CB agonists were assessed. Similar
effects to those of AEA were observed when the synthetic CB
agonist WIN 55,212-2 (1-10 mM) or the endogenous cannabinoid
2-AG (10 mM) were applied (Fig. 5E,F), except that transient
increases in mEPSC frequency were not observed. The mEPSC
frequency in pilocarpine-treated mice was reduced from
2.1360.23 Hz to 1.4560.15 Hz (n = 5; P,0.05) by WIN
55,212-2 (10 mM), while 2-AG reduced the frequency from
2.1860.52 Hz to 1.2760.26 Hz (n = 7; P,0.05). Neither drug
changed the mEPSC amplitude significantly (P.0.05). The
frequency of mEPSCs in granule cells was thus suppressed by
cannabinoid agonists in mice that had survived pilocarpine-
induced SE, but not in control mice or in mice that did not
undergo SE.
Effect of CB1R activation on population responses
To determine if coordinated granule cell population activity was
also suppressed by CB1R activation, antidromically-evoked
population responses to electrical stimulation of mossy fibers in
the hilus, and the effects of cannabinoids on those responses were
assessed. Population activity in slices from control animals was
composed of a single antidromic population spike, whose
amplitude was increased with increasing stimulus intensity, as
described previously [8]. Application of AEA (1–10 mM; n = 5) or
WIN 55,212-2 (10 mM; n = 3) had no effect on the responses in
slices from control mice. In slices from mice with TLE, responses
were more robust, usually consisting of an antidromic population
Figure 5. Effect of cannabinoid agonists on TTX-independent mEPSCs in pilocarpine-treated mice that survived SE. A. mEPSCs
recorded from a granule cell in the presence of TTX (1 mM). B. Trace showing the reduction of mEPSC frequency after application of AEA (10 mM). C.
Wash to TTX alone (20 min) showing that the effect was reversible. A1, A2, B1, B2 and C1, C2 are expanded segments of A, B and C, respectively.
Recordings were made in the presence of bicuculline (30 mM). D. Cumulative probability plot showing a change in the frequency of mEPSCs in this
cell. E and F. Cumulative charts showing effect of AEA, WIN 55,212-2 and 2-AG on mEPSC frequency (E) and amplitude (F) on pilocarpine-treated
(TLE) and control mice. Asterisk indicates significant change in mEPSC frequency (p,0.05); number of recordings shown in parentheses.
doi:10.1371/journal.pone.0010683.g005
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spike followed by a secondary after-discharge, often of long and
variable latency after the initial antidromic response [8,9]. In slices
from these animals, application of AEA (n = 10; Fig. 6) or WIN
55,212-02 (n = 5) suppressed the secondary after-discharge, with
no effect on the antidromic population spike amplitude. This effect
was prevented in each of 6 slices by pre-application of AM-251
(10 mM), indicating it was mediated by CB1R activation. In
addition to suppressing synaptic activity, CB1R activation
suppressed the secondary population afterdischarge in the dentate
gyrus of mice with pilocarpine-induced TLE, suggesting effects on
recurrent excitatory circuits.
Activation of recurrent excitatory circuit by photolysis of
caged glutamate
To more directly test the hypothesis that activity of granule cells
contributed to the enhanced sEPSCs in other granule cells in
pilocarpine-treated mice that survived SE, neurons in the granule
cell layer were selectively stimulated using focal glutamate
photolysis [8,12]. sEPSCs were measured 5 s prior to uncaging
and in 100 ms bins for 5 s after photostimulation. Glutamate was
photolytically uncaged in at least six positions within the granule
cell layer and at additional positions in the hilus and CA3 area.
Uncaging glutamate in multiple positions within the dentate gyrus
resulted in no change in sEPSC frequency in granule cells from
control mice (n = 7; Fig. 7A). However, uncaging glutamate on
granule cells in pilocarpine-treated mice that survived SE resulted
in a transient increase in EPSC frequency from a background
frequency of 3.461.1 Hz to a peak frequency of 78.1868.91 Hz
100–200 ms after uncaging (n = 11; Fig. 7B). Uncaging glutamate
in the hilus or CA3 area (n = 2–3 sites per recording) did not evoke
a synaptic response in granule cells from either control (n = 7) or
pilocarpine-treated mice (n = 11). Similar to observations in rat
models of TLE [12], activation of granule cells at a distance from
the recorded cell increased EPSCs in granule cells in pilocarpine-
treated mice that survived SE, but not in controls.
Effect of CB1R activation on photolysis-evoked EPSCs
The effect of WIN 55,212-2 was examined on photolysis-evoked
EPSC bursts in animals that survived pilocarpine-induced SE. In
these cells, WIN 55,212-2 (10 mM) attenuated photolysis-evoked
EPSCs in 5 of 6 cells (Fig. 7C,D). The mean number of evoked
EPSCs measured 100-200 ms after uncaging was decreased from
89.44612.28 to 46.67611.42 Hz by WIN 55,212-2 in these cells.
Thus, WIN 55,212-2 attenuated EPSC activity that was driven by
action potentials generated in other granule cells (n = 5; p,0.05).
CB1R Expression
Since effects were seen in animals with mossy fiber sprouting but
not control animals, we reasoned that the newly sprouted axon
terminals expressed CB1R and this may result in an increase in
CB1R protein expression in the dentate gyrus of pilocarpine-
treated mice that survived SE. The dentate gyrus was microdis-
sected to include the granule cell layer and the molecular layer in
controls and pilocarpine-treated mice that survived SE. A discrete
band at ,56 kD, corresponding to the molecular weight of the
Figure 6. Anandamide attenuated secondary population
activity that followed antidromic stimulation of granule cell
axons. A. Trace showing granule cell response to mossy fiber
stimulation in a mouse with TLE. B. Antidromically-evoked secondary
afterdischarges were reduced in the presence of 1 mM AEA. C. The
effect of AEA was reversible after 30 min wash to control ACSF.
Recordings were made in the absence of Mg2+ and the presence of
30 mM bicuculline; stimulus intensity 0.1 mA.
doi:10.1371/journal.pone.0010683.g006
Figure 7. Cannabinoid-mediated attenuation of EPSC bursts
evoked by glutamate ‘uncaging’ in the granule cell layer. Sets of
3 overlapping traces showing evoked EPSCs after photolytic release of
caged glutamate (250 mM) at the same location in the granule cell layer
of control mice and mice with TLE. Arrows indicate the time of uncaging.
A. Uncaging glutamate in the granule cell layer did not evoke a synaptic
response in control mice. B. EPSC bursts evoked in pilocarpine-treated
mice that survived SE. C. In the same cell as B, EPSC bursts were
attenuated by WIN 55,212-2 (10 mM). A1, B1 and C1 show a single
expanded trace from the group of traces shown in A, B and C. D.
Grouped data from 6 cells showing the effect of WIN 55,212-2 on EPSC
bursts evoked by photolysis of caged glutamate. Glutamate uncaging
increased EPSC frequency over baseline; ** indicate significant difference
in EPSC frequency before and after photolysis (p,0.05). * indicate a
significant reduction in EPSC frequency after application of WIN 55,212-2
during comparable post-photolysis 100 ms time periods (p,0.05).
doi:10.1371/journal.pone.0010683.g007
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CB1R receptor was identified by Western blot. Density analysis
indicated that the protein binding in tissue from pilocarpine-
treated mice that survived SE was increased by 60% over that
observed in tissue from control mice (n = 6; p,0.05; Figure 8).
Discussion
In animal models of TLE and in many patients, a permanent
change in neuronal circuitry occurs that renders the brain more
susceptible to seizure generation [1,2,6]. Among the hallmarks of
TLE are hippocampal sclerosis, neuron loss, and synaptic
reorganization in the dentate gyrus [36,37,38,39,40,41,42]. We
used a pilocarpine treated mouse model for our experiments,
which has many of the same characteristic features as seen in
human tissues, and is very similar to inducible TLE models in rats
[7,8,43]. That is, pilocarpine-induced status epilepticus triggers a
cascade of events that includes selective neuron loss, gliosis, mossy
fiber sprouting with concomitant synaptic reorganization in the
dentate gyrus, and, after a period of a few days, development of
spontaneous recurrent behavioral seizures ensues [1,7]. Mice that
survived pilocarpine-induced SE had robust mossy fiber sprouting
into the inner molecular layer of the dentate gyrus. These animals
also developed spontaneous seizures by about 3 weeks after
pilocarpine treatment [7]. Whole-cell patch-clamp recordings
performed in the absence of Mg2+ to allow excitatory network
activation [15,46,47] and in the presence of bicuculline to suppress
GABAA receptor-mediated inhibition revealed epileptiform activ-
ity, which included barrages of EPSCs in pilocarpine-treated mice
that survived SE. Under identical recording conditions, such
activity was not seen in normal animals or in mice that did not
undergo SE after pilocarpine injection, suggestive of a reorganized
synaptic circuit in the dentate gyrus of epileptic mice.
Although the relationship between synaptic reorganization and
spontaneous seizure development is indirect, analysis of the
cellular and synaptic changes observed in this and other models
may be relevant to understanding the processes that contribute to
epileptogenesis. Synaptic reorganization is hypothesized to
contribute to seizure susceptibility, but the new connections also
may represent a potential target for attenuating activity, which is
unique to the reorganized circuit. Most antiepileptic drugs were
developed in unaltered brain systems, and thus they do not target
the abnormal synaptic circuitry that develops in TLE. Identifying
pharmacological targets on the newly-formed axon terminals may
result in development of new strategies for suppressing seizures
[44,45]. Since CB1R are generally considered to be located on
synaptic terminals in the dentate gyrus, we assessed effects of
activating those receptors on glutamatergic terminals in a murine
model of TLE. Effects on GABA release have yet to be assessed in
this model, but the present results suggest that CB1R are expressed
functionally in excitatory circuits to a much greater degree in the
reorganized dentate gyrus than in control mice. The robust
CB1R-mediated reduction of mEPSC frequency in slices from
epileptic mice suggests a presynaptic location for the receptors on
glutamatergic synaptic terminals. Input resistance and resting
membrane potential were not altered by CB1R activation, further
suggesting that postsynaptic changes in cellular activity did not
account for the suppression of glutamate release. Binding CB1R
suppressed secondary population afterdischarges subsequent to
antidromic activation of the granule cells. Secondary discharges in
this and other models of TLE have been shown to be driven by
action potentials in neurons contained within the slice that are
activated by the antidromically-induced action potential in granule
cells [8,9]. Such afterdischarges are not typically seen in controls,
especially when the entorhinal cortex has been completely excised
from the slice, as in the present studies. This suggests that the
circuit upon which the agonists acted was part of the new
recurrent excitatory circuitry that forms after hippocampal
sclerosis and development of TLE. These results are consistent
with the hypothesis that CB1R activation suppresses recurrent
excitatory activity in epileptic mice, which does not occur in the
granule cell layer of control mice.
In addition to suppressing circuit activation induced by
antidromic stimulation of mossy fibers, cannabinoid agonists
reduced EPSCs evoked by glutamate photolysis stimulation of
other granule cells. These data are consistent with the hypothesis
that the cannabinoid agonists mediated suppression of glutamate
release subsequent to binding CB1R located on sprouted glutama-
tergic terminals of the reorganized recurrent excitatory circuit. This
binding was sufficient to reduce network excitability. In normal
animals, CB1R binding can inhibit glutamatergic input arising from
mossy cells [48]. Mossy cells and CA3 pyramidal cells normally
project onto granule cells [49,50], and CB1R-mediated inhibition of
these terminals might also contribute to the enhanced effect in
animals with TLE, especially if terminals of surviving cells sprout.
However, glutamate photolysis in either the CA3 pyramidal cell
layer or the hilus failed to elicit synaptic responses in the dentate
gyrus, indicating that such connections were not prominent in our
slices. It remains possible that sprouted axons of glutamatergic
inputs from other areas contribute to the increased excitability, and
that CB1R expression on such terminals may also play a role in the
effect of cannabinoids. However, sprouted mossy fibers appear to
play the major role in this new circuitry [8,10,13] and CB1R-
mediated responses were obvious when granule cells were activated.
The present data suggest a presynaptic location of CB1R,
consistent with other studies indicating that CB1R are present on
pre-synaptic nerve terminals elsewhere in the hippocampal
formation [24], although they are typically thought to be located
on terminals of GABAergic neurons [51,52],. Therefore, the usual
action of cannabinoids would be to disinhibit granule cells, an action
which might be expected to increase the likelihood of seizures.
However, CB1R agonists suppress seizure activity in rats that have
developed TLE[31,53], consistent with their location in glutama-
Figure 8. Western blot detection of cannabinoid type 1
receptor (CB1R) expression. A. Diagram of dentate gyrus illustrating
the area that was micro-dissected (box) for analysis. B. Western blot
showing CB1R expression in pilocarpine-treated mice that survived SE
and developed TLE compared to untreated mice. Actin was used as the
loading control, which did not change significantly. C. Graph showing
cumulative (60%) increase in CB1R expression in mice with TLE versus
controls (n = 6; p,0.05). * indicates significance. IML, inner molecular
layer; GCL, granule cell layer; PML, polymorphic layer.
doi:10.1371/journal.pone.0010683.g008
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tergic circuits. Although the effect observed here of CB1R agonists
on connections in the dentate gyrus represent only indirect evidence
of CB1R-mediated anticonvulsant activity, the response we
observed in slices is consistent with the effects seen in vivo.
In the normal dentate gyrus, CB1R on terminals of hilar mossy
cells likely accounts for their presence in the inner molecular layer
and these receptors are believed to mediate mossy cell terminal-
specific DSE in granule cells [48]. We found no significant effects of
CB1R activation on overall sEPSCs or mEPSCs in control mice, but
effects of CB1R activation specifically on mossy cell inputs were not
tested. Effects of cannabinoid agonists on putative granule cell-to-
granule cell connections were inhibited, but only in animals with
mossy fiber sprouting. Endogenous cannabinoid release (e.g.,
anandamide, 2-AG) is thought to be activity-dependent, and levels
of endogenous cannabinoids are increased during seizures [31,54].
We did not directly assess activity of endogenous cannabinoid release
in the present study, but application of AM251 alone had little effect
on EPSCs. Endogenous cannabinoid release may not necessarily be
chronically elevated in slices from epileptic mice, even though
glutamatergic synaptic activity was enhanced. Also, our recording
conditions may not have been optimal for detecting endogenous
activity. It will be of interest to determine if evoked endogenous
cannabinoid release is altered in the dentate gyrus of mice with TLE.
The density of CB1R has been reported to be down regulated in
the dentate gyrus in TLE patients and some animal models
[29,30]. The loss of hilar mossy cells and GABAergic interneurons
during the development of TLE in similar models [55] and the
concomitant loss of CB1R associated with these nerve terminals
could contribute to a reduction in the density of CB1R observed in
immunohistochemical analyses. Increases in CB1R expression
were shown in the hippocampus, if not in the dentate gyrus, in
other models of TLE [31,56,57], and receptor levels appear to
change biphasically in the whole hippocampus over time after SE,
being reduced initially and then increased over several weeks [29].
Notably, different CB1R antibodies show different distribution
patterns, depending on the binding epitope [58,59]. We used
Western blot to minimize this issue and detected an increase in the
total CB1R protein expression in the temporal half of the isolated
dentate gyrus of pilocarpine-treated epileptic mice with robust
mossy fiber sprouting. Receptors on axon terminals arising from a
variety of areas could contribute to the increase in overall
expression we observed, including on GABAergic terminals, so
electron microscopic analyses may be necessary to demonstrate
conclusively an increase in receptors associated with mossy fibers.
However, while spatial resolution is limited with the Western blot
technique, these results were consistent with our electrophysiolog-
ical data indicating an increase in CB1R-dependent suppression of
local glutamatergic synaptic connections, probably between
granule cells. This suggests that CB1R could be made in the cell
body of the granule cells and be trafficked to the terminals.
Message for CB1R in granule cells is normally low in the dentate
gyrus, but not absent [26,60,61], and seizures or SE can cause up-
regulation of a variety of genes [62]. Whether CB1R message is up
regulated after SE in this model is not known but our data would
be consistent with that hypothesis.
Many cannabinoid agonists bind both CB1R and CB2R, and
AEA is also an agonist at TRPV1 receptors, activation of which
can enhance release of neurotransmitter by increasing intracellular
concentrations of Ca2+ [63]. TRPV1 receptors have been shown
to exist in the dentate gyrus [63]. The inhibitory effect of AEA was
mimicked by WIN 55,212-2 and 2-AG, which are not known to
efficiently bind TRPV1 receptors. TRPV1 activation generally
increases glutamate release; it seems unlikely that TRPV1
contributes to the decrease in synaptic activity. Notably, an
AEA-induced transient increase in EPSC frequency was observed
in a subset of neurons and involvement of TRPV1 in that response
has been identified [64]. Finally, inhibitory effects of CB1R
agonists were blocked by AM251, a relatively selective CB1R
antagonist/inverse agonist. Reduction of the frequency of
glutamate-evoked EPSCs and antidromically-evoked secondary
population activity by CB1R activation suggests that the
remodeled circuit expresses functional CB1R. In addition to
blocking CB1R-mediated effects, unmasking of TRPV1-mediated
effects of AEA in the presence of CB1R antagonists might be
expected to transiently enhance recurrent excitation in the dentate
gyrus in some cases. This may be relevant to a recent report
indicating recurrence of seizures in a TLE patient treated with a
CB1R antagonist [33].
Both endogenous and synthetic cannabinoid agonists reduced
the frequency of the excitatory glutamatergic events in addition to
blocking the epileptiform barrages originating from activity in
other granule cells in the synaptically reorganized dentate gyrus of
mice with TLE. The ability of cannabinoids to block epileptiform
discharges in this model of TLE could have significant therapeutic
implications, particularly in patients with mesial temporal sclerosis
and mossy fiber sprouting. However, further study is needed to
understand the interactions between cannabinoids and other
receptor targets as well as cannabinoid effects in other brain areas
affected in TLE or in other TLE models, where axon sprouting
may be significant but not as robust as in the pilocarpine-treated
mouse.
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